SCHEMBL1101302

SCHEMBL1101302

CCC(S)N1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.32
SLC6A3 Q01959 2/20 0.32
SLC6A2 P23975 1/20 0.32
FDPS P14324 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24693242 0.97
SCHEMBL9563864 0.80 SLC6A3 (0.37) SLC6A4SLC6A3SLC6A2
SCHEMBL28090989 0.75 ALDH1A1 (0.39)
SCHEMBL28091490 0.75 SMN1; SMN2 (0.33)
SCHEMBL608461 0.75 SLC6A4 (0.34) SLC6A4SLC6A3SLC6A2
SCHEMBL20547958 0.75 HRH3 (0.38) SLC6A4SLC6A3SLC6A2
SCHEMBL288088 0.72 FDPS (0.33) SLC6A4SLC6A3SLC6A2FDPS
SCHEMBL19334589 0.72 SLC6A4 (0.39) SLC6A4SLC6A3FDPS
SCHEMBL3309623 0.72 SLC6A4 (0.39) SLC6A4SLC6A3FDPS
SCHEMBL21862178 0.70 CYP3A4 (0.37) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105960246-A Novel cyclosporin derivatives and use thereof 美国科技环球有限公司 2016-09-21 CN disclosed
CN-103249424-B For treating and preventing the novel cyclosporin derivatives of virus infection 河北鲲翔济世医药科技有限公司 2016-08-10 CN disclosed
US-8153660-B2 Piperidyl-propane-thiol CCR3 modulators BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-10 US disclosed
US-8153660-B2 Piperidyl-propane-thiol CCR3 modulators BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-10 US disclosed
US-8148403-B2 Substituted piperidyl-propane-thiols BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-03 US disclosed
US-8148403-B2 Substituted piperidyl-propane-thiols BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-03 US disclosed
US-8148403-B2 Substituted piperidyl-propane-thiols BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-03 US disclosed
EP-2079725-B1 PIPERIDYL-PROPANE-THIOL CCR3 MODULATORS BOEHRINGER INGELHEIM INT (DE) 2011-12-14 EP disclosed
EP-2079725-B1 PIPERIDYL-PROPANE-THIOL CCR3 MODULATORS BOEHRINGER INGELHEIM INT (DE) 2011-12-14 EP disclosed
EP-2079731-B1 NOVEL SUBSTITUTED PIPERIDYL-PROPANE-THIOLS BOEHRINGER INGELHEIM INT (DE) 2011-09-14 EP disclosed
US-20100317634-A1 PIPERIDYL-PROPANE-THIOL CCR3 MODULATORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-12-16 US disclosed
US-20100317634-A1 PIPERIDYL-PROPANE-THIOL CCR3 MODULATORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-12-16 US disclosed
EP-2079731-A1 NOVEL SUBSTITUTED PIPERIDYL-PROPANE-THIOLS Boehringer Ingelheim International GmbH (DE) 2009-07-22 EP disclosed
EP-2079725-A1 PIPERIDYL-PROPANE-THIOL CCR3 MODULATORS Boehringer Ingelheim International GmbH (DE) 2009-07-22 EP disclosed
EP-2079725-A1 PIPERIDYL-PROPANE-THIOL CCR3 MODULATORS Boehringer Ingelheim International GmbH (DE) 2009-07-22 EP disclosed
EP-2079731-A1 NOVEL SUBSTITUTED PIPERIDYL-PROPANE-THIOLS Boehringer Ingelheim International GmbH (DE) 2009-07-22 EP disclosed
WO-2008049875-A1 NOVEL SUBSTITUTED PIPERIDYL-PROPANE-THIOLS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-05-02 WO disclosed
WO-2008049875-A1 NOVEL SUBSTITUTED PIPERIDYL-PROPANE-THIOLS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-05-02 WO disclosed
WO-2008049874-A1 PIPERIDYL-PROPANE-THIOL CCR3 MODULATORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-05-02 WO disclosed
WO-2008049874-A1 PIPERIDYL-PROPANE-THIOL CCR3 MODULATORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317634-A1 PIPERIDYL-PROPANE-THIOL CCR3 MODULATORS CCR3, CCR1, CCRL2 SLC6A4 1490/4885SLC6A3 592/4885SLC6A2 2418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.